IIL - Intravenous Infusions Limited
Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.
Intravenous Infusions Limited is listed on the Ghana Stock Exchange (GSE). Intravenous Infusions is traded on the GSE under the ticker symbol “IIL”. The International Securities Identification Number (ISIN) of GSE:IIL is GH0000001258. Intravenous Infusions Limited is currently the 32nd most valuable stock on the GSE with a market capitalization of GHS 13.7 million, which is about 0.013% of the Ghana Stock Exchange equity market.
| Last Trading Results | |
|---|---|
| Opening Price | |
| Day’s Low Price | |
| Day’s High Price | |
| Traded Volume | 0 |
| Number of Deals | 0 |
| Gross Turnover | 0.00 |
| Growth & Valuation | |
|---|---|
| Earnings Per Share | 0.0039 |
| Price/Earning Ratio | 12.82 |
| Dividend Per Share | 0.0028 |
| Dividend Yield | 5.6% |
| Shares Outstanding | 274M |
| Market Capitalization | 13.7M |
IIL Stock Market Performance
| 1WK | 4WK | 3MO |
|---|---|---|
| 6MO | 1YR | YTD |
|---|---|---|
| +25% |
The current share price of Intravenous Infusions Limited (IIL) is GHS 0.05. IIL closed its last trading day (Friday, November 8, 2024) at 0.05 GHS per share on the Ghana Stock Exchange (GSE).
Intravenous Infusions is the 13th most traded stock on the Ghana Stock Exchange over the past three months (Aug 26 - Nov 21, 2024). IIL has traded a total volume of 88,952 shares valued at GHS 4,450 over the period, with an average of 1,412 traded shares per session. A volume high of 50,000 was achieved on October 17th for the same period. The table below details the last 10 trading days of activity of Intravenous Infusions on the Ghana Stock Exchange.
| Date | Volume | Close | Change | Change% |
|---|---|---|---|---|
| 2024-11-08 | 9,616 | 0.05 | ||
| 2024-10-17 | 50,000 | 0.05 | ||
| 2024-10-02 | 300 | 0.05 | ||
| 2024-09-24 | 24 | 0.05 | ||
| 2024-09-13 | 29,012 | 0.05 | ||
| 2024-08-09 | 14,358 | 0.05 | ||
| 2024-07-23 | 12,500 | 0.05 | ||
| 2024-07-18 | 41,642 | 0.05 | ||
| 2024-07-17 | 19,871 | 0.05 | ||
| 2024-07-15 | 940 | 0.05 |
Profile of Intravenous Infusions Limited
Intravenous Infusions Limited operates in the Health Care sector.
Factsheet of Intravenous Infusions Limited
- Sector
- Health Care
- Industry
- —
- Address
- Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
- Telephone
- +233-342-020-151
- info@iil.com.gh
- Website
- www.iil.com.gh
IIL Industrial Market Competitors
Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have one market competitor who is also engaged in the Health Care sector. The table below presents an overview of their market standing.
| Code | Name | M. Cap. | Close | YTD |
|---|---|---|---|---|
| DASPHARMA | Dannex Ayrton Starwin Plc | 32.2M | 0.38 | -5% |
